References
- Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64–74.
- Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005;72:1277–1282.
- Luzzatto L. Genetics of red cells and susceptibility to malaria. Blood. 1979;54:961–976.
- Luzzatto L, Bienzle U. The malaria/G.-6-P.D. hypothesis. Lancet. 1979;1:1183–1184.
- Wolach B, Ashkenazi M, Grossmann R, et al. Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel. Pediatr Res. 2004;55:807–813.
- Tsai KJ, Hung IJ, Chow CK, et al. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes. FEBS Lett. 1998;436:411–414.
- Vives Corrons JL, Feliu E, Pujades MA, et al. Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona). Blood. 1982;59:428–434.
- Gray GR, Stamatoyannopoulos G, Naiman SC, et al. Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet. 1973;2:530–534.
- Spolarics Z, Siddiqi M, Siegel JH, et al. Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients. Crit Care Med. 2001;29:728–736.
- Abu-Osba YK, Mallouh AA, Hann RW. Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr. 1989;114:748–752.
- Rostami-Far Z, Ghadiri K, Rostami-Far M, et al. Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis. J Med Life. 2016;9:34–38.
- Sanna M, Caocci G, Ledda A, et al. Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia. Leuk Lymphoma. 2017;58:2558--2564.
- Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol. 2000;12:64–76.
- Missall TA, Lodge JK, McEwen JE. Mechanisms of resistance to oxidative and nitrosative stress: implications for fungal survival in mammalian hosts. Eukaryot Cell. 2004;3:835–846.
- Ullmann BD, Myers H, Chiranand W, et al. Inducible defense mechanism against nitric oxide in Candida albicans. Eukaryot Cell. 2004;3:715–723.
- Phillips AJ, Sudbery I, Ramsdale M. Apoptosis induced by environmental stresses and amphotericin B in Candida albicans. Proc Natl Acad Sci USA. 2003;100:14327–14332.